Related Experiment Video
Updated: Jun 21, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Small airway asthma therapy, challenges, and the future.
1Center for Allergy, Asthma and Immunology, Creighton University, Omaha, NE 68131, USA. tbcasale@creighton.edu
Postgraduate Medicine
|August 12, 2009
Summary
New inhaled corticosteroid formulations improve asthma treatment by delivering medication more effectively to small airways. This enhanced lung targeting allows for reduced drug doses and more efficient treatment of asthmatic inflammation.
Area of Science:
- Pulmonology
- Pharmacology
- Drug Delivery Systems
Background:
- Small airway pathology is a significant therapeutic target in asthma management.
- Conventional inhaled corticosteroids (CFC-based) have limitations in reaching small airways due to large aerosol particle size.
- Asthma treatment requires effective delivery to the distal lung for optimal therapeutic outcomes.
Purpose of the Study:
- To evaluate the efficacy of novel hydrofluoroalkane (HFA)-based corticosteroid formulations for improved small airway targeting in asthma.
- To assess the potential for reduced drug dosage with new formulations due to enhanced lung delivery.
- To investigate the impact of particle size on inhaled corticosteroid delivery to peripheral lung regions.
Main Methods:
- Comparison of aerosol particle size distribution between conventional CFC-based and novel HFA-based inhaled corticosteroid formulations.
- Assessment of lung deposition and targeting efficiency of the new formulations in preclinical or clinical models.
- Evaluation of therapeutic efficacy and dose-response relationship in asthma models using both formulation types.
Main Results:
- New HFA-based formulations generate aerosols with significantly smaller particle sizes compared to conventional CFC-based formulations.
- Smaller particle sizes facilitate enhanced delivery and targeting of corticosteroids to the small airways and distal lung.
- Improved lung targeting with new formulations leads to increased therapeutic effectiveness at reduced drug doses.
Conclusions:
- Novel HFA-based inhaled corticosteroid formulations offer superior delivery to small airways in asthma.
- These advanced formulations represent a significant improvement in inhaled corticosteroid therapy, enabling reduced dosages and enhanced treatment efficacy.
- The development of new propellant technologies is crucial for optimizing drug delivery to the peripheral lung in respiratory diseases like asthma.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...